Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Controls in Experiments01:13

Controls in Experiments

11.4K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
11.4K
Blind Procedures02:07

Blind Procedures

12.2K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.2K
Data Collection by Experiments01:13

Data Collection by Experiments

25.3K
Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public...
25.3K
Blinding01:11

Blinding

2.7K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Changing the Context of Use Change the Value Proposition of CiPA?

Clinical pharmacology and therapeutics·2026
Same author

Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety.

Nature reviews. Drug discovery·2025
Same author

Corrigendum to "Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As" [J. Pharmacol. Toxicol. Methods 123 (2023) 107270].

Journal of pharmacological and toxicological methods·2025
Same author

Legacy hERG study data in contemporary integrated risk assessments - mitigating the risk of protocol and positive control article differences.

Journal of pharmacological and toxicological methods·2025
Same author

Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studies.

Journal of pharmacological and toxicological methods·2025
Same author

The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs.

Journal of pharmacological and toxicological methods·2025

Related Experiment Video

Updated: Sep 17, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

735

Using pre-existing control data to set expectations in preclinical studies.

Jenna K Felli1, Derek J Leishman1, Meredith A Steeves1

  • 1Eli Lilly and Company, Indianapolis, USA.

Regulatory Toxicology and Pharmacology : RTP
|July 3, 2025
PubMed
Summary
This summary is machine-generated.

This study uses existing control data and probabilistic methods to predict preclinical toxicology study outcomes. This approach reduces the need for live subjects by setting expectations for experimental results beforehand.

Keywords:
Historical controlsHistorical dataProbabilityVirtual controls

More Related Videos

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.8K

Related Experiment Videos

Last Updated: Sep 17, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

735
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.8K

Area of Science:

  • Preclinical toxicology
  • Biostatistics
  • Drug development

Background:

  • Live subjects are essential for preclinical toxicological studies.
  • Ethical and cost considerations necessitate reducing live animal use.
  • Leveraging existing control data offers a potential solution.

Purpose of the Study:

  • To present a conceptual framework for limiting live subjects in toxicology studies.
  • To utilize pre-existing control data for setting a priori expectations of study outcomes.
  • To establish probabilistic methods for defining expected results.

Main Methods:

  • Utilizing curated datasets of control subject metrics.
  • Applying probabilistic methods, including T-distribution for continuous endpoints with small sample sizes.
  • Employing bootstrapping for discrete endpoints or when sample average is not a reliable proxy.

Main Results:

  • Demonstrated the feasibility of setting a priori expectations for experimental outcomes.
  • Showcased the application of T-distribution and bootstrapping for different endpoint types.
  • Provided a method to understand endpoint behavior in untreated populations.

Conclusions:

  • Probabilistic approaches using existing control data can reduce reliance on live subjects.
  • These methods aid in establishing a priori expectations for "normalcy" in toxicology studies.
  • The conceptual approach offers a pathway to more efficient and ethical preclinical research.